Keith T. Flaherty, MD

Massachusetts General Hospital

Academic Titles

Professor, Medicine, Harvard Medical School

Research Program Affiliation

Co-Leader, Developmental Therapeutics

Member, Melanoma

Leadership Roles

Member, Clinical Science Coordinating Committee

Research Abstract

Dr. Flaherty's research focuses on the understanding of novel, molecularly targeted therapies in cancer. In this context he focused on the development of response and predictive biomarkers to define the mechanisms of action and resistance of novel therapies, as well as to identify the optimal target population.